# BNTC (Benitec Biopharma Inc.) - SEC EDGAR Financial Statements

> Benitec Biopharma Inc. reported $179.1M in total assets and a net loss of $49.51M through June 30, 2026 from SEC EDGAR filings.

- Canonical: https://convexityos.com/fundamentals/BNTC
- Markdown: https://convexityos.com/fundamentals/BNTC.md
- SEC CIK: 0001808898
- Reporting currency: USD
- Latest filing period: September 30, 2026
- Last synced: Nov 20, 2026, 05:39 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001808898&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | FY 2026 | -- | Jun 30, 2026 |
| Operating Income | FY 2026 | -$55.87M | Operating profit |
| Net Income | FY 2026 | -$49.51M | GAAP bottom line |
| Diluted EPS | FY 2026 | -$1.00 | Split-adjusted |
| Free Cash Flow | FY 2026 | -$16.62M | Operating CF less CapEx |
| Cash & ST Investments | Sep 30, 2026 | $176.4M | Total debt: $642K |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | -- | -- | $0 | $75K | $73K | $59K | $102K | $12.20M |
| Research & Development | $23.39M | $18.33M | $15.61M | $12.77M | $11.27M | $7.02M | $3.00M | $4.57M |
| Total Operating Expenses | $51.19M | $41.77M | $22.49M | $19.16M | $17.93M | $13.65M | $8.38M | $9.62M |
| **Operating Income** | -$51.19M | -$41.77M | -$22.49M | -$19.08M | -$17.85M | -$13.60M | -$8.28M | $2.58M |
| **EBITDA** | -$51.13M | -$41.70M | -$22.40M | -$18.95M | -$17.69M | -$13.37M | -$8.09M | $2.74M |
| Income Tax Expense | $0 | -- | -- | -- | -- | -- | -- | -- |
| **Net Income** | -$45.55M | -$37.92M | -$21.75M | -$19.56M | -$18.21M | -$13.88M | -$8.27M | $2.61M |
| Basic EPS | -$0.98 | -$1.05 | -$1.22 | -$0.03 | -$0.07 | -$0.10 | -$0.26 | $0.10 |
| **Diluted EPS** | -$0.98 | -$1.05 | -$1.22 | -$0.03 | -$0.07 | -$0.10 | -$0.26 | $0.10 |
| Basic Shares Outstanding | 46.6M | 36.2M | 18.4M | 745.0M | 258.4M | 135.8M | 32.3M | 27.1M |
| Diluted Shares Outstanding | 46.6M | 36.2M | 18.4M | 745.0M | 258.4M | 135.8M | 32.3M | 27.1M |

### Income Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | -- | -- | $0 | $0 | $0 | -- | $0 | $0 |
| Research & Development | $8.62M | $7.89M | $6.30M | $5.83M | $3.37M | $2.87M | $6.50M | $5.38M |
| Total Operating Expenses | $14.48M | $14.43M | $13.58M | $13.38M | $9.80M | $9.83M | $15.34M | $10.80M |
| **Operating Income** | -$14.48M | -$14.43M | -$13.58M | -$13.38M | -$9.80M | -$9.83M | -$15.34M | -$10.80M |
| **EBITDA** | -$14.46M | -$14.41M | -$13.57M | -$13.36M | -$9.79M | -$9.82M | -$15.32M | -$10.79M |
| **Net Income** | -$12.93M | -$12.81M | -$11.94M | -$11.84M | -$8.96M | -$8.80M | -$14.50M | -$9.55M |
| Basic EPS | -$0.26 | -- | -$0.24 | -$0.26 | -$0.22 | -$0.21 | -$0.38 | -$0.26 |
| **Diluted EPS** | -$0.26 | -- | -$0.24 | -$0.26 | -$0.22 | -$0.21 | -$0.38 | -$0.26 |
| Basic Shares Outstanding | 49.5M | -- | 49.4M | 46.0M | 41.5M | 41.2M | 38.6M | 37.3M |
| Diluted Shares Outstanding | 49.5M | -- | 49.4M | 46.0M | 41.5M | 41.2M | 38.6M | 37.3M |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $180.0M | $97.74M | $50.87M | $2.48M | $4.06M | $19.77M | $9.80M | $15.72M |
| **Cash & Short-Term Investments** | $180.0M | $97.74M | $50.87M | $2.48M | $4.06M | $19.77M | $9.80M | $15.72M |
| Other Current Assets | $1.59M | $628K | $516K | $1.18M | $741K | $799K | $949K | $502K |
| **Total Current Assets** | $181.7M | $98.52M | $51.67M | $3.73M | $4.82M | $20.61M | $10.81M | $18.76M |
| Property, Plant & Equipment, Net | $178K | $131K | $179K | $87K | $222K | $375K | $374K | $470K |
| Other Non-Current Assets | $12K | $28K | $62K | $97K | $135K | $185K | -- | -- |
| **Total Non-Current Assets** | $938K | $1.07M | $536K | $735K | $1.15M | $771K | $778K | $479K |
| **Total Assets** | $182.6M | $99.59M | $52.21M | $4.46M | $5.97M | $21.38M | $11.59M | $19.23M |
| Accounts Payable | $913K | $201K | $1.35M | $1.14M | $422K | $274K | $282K | $1.47M |
| **Total Current Liabilities** | $5.34M | $1.80M | $4.92M | $3.98M | $2.53M | $1.37M | $1.14M | $2.64M |
| **Total Non-Current Liabilities** | $266K | $495K | $38K | $284K | $559K | $0 | $213K | $0 |
| **Total Liabilities** | $5.61M | $2.30M | $4.96M | $4.26M | $3.09M | $1.37M | $1.35M | $2.64M |
| **Total Debt (incl. Leases)** | $762K | $849K | $284K | $559K | $811K | $213K | $405K | -- |
| Common Stock | $3.0K | $2.0K | $1.0K | $0 | $0 | $1.0K | $0 | $1.0K |
| Retained Earnings | -$273.7M | -$228.2M | -$190.3M | -$167.9M | -$148.3M | -$130.1M | -$116.6M | -$108.9M |
| Accumulated Other Comp. Income | -$963K | -$839K | -$892K | -$830K | -$1.25M | -$1.46M | -$1.95M | -$1.86M |
| **Total Stockholders' Equity** | $177.0M | $97.30M | $47.25M | $202K | $2.88M | $20.01M | $10.24M | $16.59M |
| Total Equity | $177.0M | $97.30M | $47.25M | $202K | $2.88M | $20.01M | $10.24M | $16.59M |

### Balance Sheet (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $176.4M | $180.0M | $184.8M | $188.8M | $94.48M | $97.74M | $103.6M | $78.28M |
| **Cash & Short-Term Investments** | $176.4M | $180.0M | $184.8M | $188.8M | $94.48M | $97.74M | $103.6M | $78.28M |
| Other Current Assets | $1.62M | $1.59M | $1.14M | $562K | $480K | $628K | $361K | $366K |
| **Total Current Assets** | $178.1M | $181.7M | $186.0M | $189.6M | $95.08M | $98.52M | $104.0M | $78.71M |
| Property, Plant & Equipment, Net | $110K | $178K | $116K | $115K | $118K | $131K | $145K | $151K |
| Other Non-Current Assets | $244K | $12K | $12K | $11K | $20K | $28K | $35K | $42K |
| **Total Non-Current Assets** | $994K | $938K | $983K | $1.09M | $948K | $1.07M | $1.20M | $355K |
| **Total Assets** | $179.1M | $182.6M | $187.0M | $190.7M | $96.03M | $99.59M | $105.2M | $79.07M |
| Accounts Payable | $1.02M | $913K | $635K | $1.02M | $271K | $201K | $433K | $593K |
| **Total Current Liabilities** | $9.08M | $5.34M | $3.27M | $2.80M | $2.02M | $1.80M | $7.03M | $3.09M |
| **Total Non-Current Liabilities** | $374K | $266K | $394K | $519K | $403K | $495K | $613K | $38K |
| **Total Liabilities** | $9.45M | $5.61M | $3.67M | $3.32M | $2.43M | $2.30M | $7.64M | $3.13M |
| **Total Debt (incl. Leases)** | $642K | $762K | $876K | $987K | $817K | $849K | $959K | $137K |
| Common Stock | $4.0K | $3.0K | $3.0K | $3.0K | $2.0K | $2.0K | $2.0K | $2.0K |
| Retained Earnings | -$286.6M | -$273.7M | -$260.9M | -$249.0M | -$237.1M | -$228.2M | -$212.0M | -$202.7M |
| Accumulated Other Comp. Income | -$947K | -$963K | -$952K | -$883K | -$750K | -$839K | -$716K | -$688K |
| **Total Stockholders' Equity** | $169.6M | $177.0M | $183.3M | $187.4M | $93.60M | $97.30M | $97.57M | $75.94M |
| Total Equity | $169.6M | $177.0M | $183.3M | $187.4M | $93.60M | $97.30M | $97.57M | $75.94M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$45.55M | -$37.92M | -$21.75M | -$19.56M | -$18.21M | -$13.88M | -$8.27M | $2.61M |
| Depreciation & Amortization | $58K | $66K | $87K | $136K | $167K | $231K | $190K | $158K |
| Stock-Based Compensation | $26.41M | $17.43M | $830K | $452K | $870K | $634K | $237K | $672K |
| **Operating Cash Flow** | -$16.52M | -$23.59M | -$19.40M | -$18.01M | -$15.90M | -$12.83M | -$7.54M | $4.79M |
| Capital Expenditure | -$105K | -$18K | -$179K | -$1.0K | -$13K | -$221K | -$95K | -$404K |
| **Free Cash Flow** | -$16.62M | -$23.61M | -$19.58M | -$18.01M | -$15.91M | -$13.05M | -$7.63M | $4.39M |
| **Investing Cash Flow** | -$105K | -$18K | -$179K | -$1.0K | -$13K | -$221K | -$94K | -$400K |
| Common Stock Issued | $104.5M | $30.46M | -- | $17.88M | -- | $25.75M | $2.25M | -- |
| **Financing Cash Flow** | $98.98M | $70.48M | $68.03M | $16.02M | -- | $22.52M | $1.77M | -- |
| **Net Change in Cash** | $82.23M | $46.93M | $48.44M | -$1.59M | -$15.71M | $9.97M | -- | -- |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$12.93M | -$12.81M | -$11.94M | -$11.84M | -$8.96M | -$8.80M | -$14.50M | -$9.55M |
| Depreciation & Amortization | $17K | $17K | $14K | $14K | $13K | $14K | $13K | $14K |
| Stock-Based Compensation | $5.51M | $6.26M | $7.59M | $7.38M | $5.18M | $6.11M | $7.74M | $3.14M |
| **Operating Cash Flow** | -$3.62M | -$4.94M | -$4.45M | -$3.78M | -$3.35M | -$8.21M | -$3.09M | -$7.70M |
| **Investing Cash Flow** | $0 | -$79K | -$15K | -$11K | $0 | $0 | -$6.0K | -$12K |
| **Financing Cash Flow** | $0 | $241K | $506K | $98.23M | $0 | $2.74M | $28.21M | $17.87M |
| **Net Change in Cash** | -$3.60M | -$4.79M | -$4.03M | $94.31M | -$3.27M | -$5.59M | $25.10M | $10.44M |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Operating Margin** | -- | -- | -- | -25441.3% | -24457.5% | -23044.1% | -8118.6% | 21.2% |
| **Net Profit Margin** | -- | -- | -- | -26082.7% | -24942.5% | -23528.8% | -8111.8% | 21.4% |
| Return on Equity (ROE) | -25.7% | -39.0% | -46.0% | -9684.2% | -631.8% | -69.4% | -80.8% | 15.7% |
| Return on Assets (ROA) | -24.9% | -38.1% | -41.7% | -438.2% | -304.8% | -64.9% | -71.4% | 13.6% |
| Current Ratio | 34.00x | 54.67x | 10.49x | 0.94x | 1.90x | 15.05x | 9.51x | 7.10x |
| Quick Ratio | 33.68x | 54.24x | 10.33x | 0.62x | 1.60x | 14.44x | 8.63x | 5.95x |
| Debt to Equity | 0.00x | 0.01x | 0.01x | 2.77x | 0.28x | 0.01x | 0.04x | -- |
| **Revenue Growth (YoY)** | -- | -- | -100.0% | +2.7% | +23.7% | -42.2% | -99.2% | -- |
| Operating Income Growth (YoY) | -- | -- | -- | -- | -- | -- | -420.6% | -- |
| **Net Income Growth (YoY)** | -- | -- | -- | -- | -- | -- | -417.1% | -- |
| EPS Growth (YoY) | -- | -- | -- | -- | -- | -- | -365.5% | -- |
| Operating Cash Flow Growth (YoY) | -- | -- | -- | -- | -- | -- | -257.3% | -- |
| Free Cash Flow Growth (YoY) | -- | -- | -- | -- | -- | -- | -274.0% | -- |
| 5Y Revenue / Share Growth | -- | -- | -100.0% | -- | -- | -- | -- | -- |
| 5Y Net Income / Share Growth | -- | -- | -1329.5% | -- | -- | -- | -- | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Return on Equity (ROE) | -29.2% | -25.7% | -22.7% | -23.5% | -44.7% | -39.0% | -34.7% | -31.1% |
| Return on Assets (ROA) | -27.6% | -24.9% | -22.2% | -23.1% | -43.6% | -38.1% | -32.2% | -29.9% |
| Current Ratio | 19.62x | 34.00x | 56.82x | 67.69x | 46.95x | 54.67x | 14.80x | 25.48x |
| Quick Ratio | 19.43x | 33.68x | 56.43x | 67.40x | 46.66x | 54.24x | 14.74x | 25.34x |
| Debt to Equity | 0.00x | 0.00x | 0.00x | 0.01x | 0.01x | 0.01x | 0.01x | 0.00x |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
